1 / 35

The golden hour(s) for severe sepsis and septic shock treatment

The golden hour(s) for severe sepsis and septic shock treatment. D. Matamis M.D, Papageorgiou Hospital Thessaloniki - Greece. DO 2 – VO 2 - SvO 2. VO 2 -VCO 2 production during shivering. VO 2 -VCO 2 production during agitation. VO 2 -DO 2 dependence. ScvO 2 jugular SvO 2

aolani
Download Presentation

The golden hour(s) for severe sepsis and septic shock treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The golden hour(s) for severe sepsis and septic shock treatment D. Matamis M.D, Papageorgiou Hospital Thessaloniki - Greece

  2. DO2 – VO2 - SvO2

  3. VO2-VCO2 production during shivering

  4. VO2-VCO2 production during agitation

  5. VO2-DO2 dependence

  6. ScvO2 jugular SvO2 hepatic SvO2 renal SvO2 coronary sinus SvO2 mesenteric SvO2 Regional SvO2

  7. DO2/VO2 imbalance Decrease in O2 delivery Increase in O2 Consumption O2 reserves 25% of the Ο2 delivered in the periphery is used Is it reasonable? - CaO2 =20 ml/dl - (a-v)DO2 = 5 ml/dl -SvO2 75%, Marathon Runners Deep Divers (mammals, Birds) Tissue Hypoxia

  8. ICU patients Trauma Severe Sepsis Extensive Surgery If we increase DO2 Mortality Goals of the hemodynamic optimization DO2 ? SvO2 ?, ScvO2 ? C.I ? Tissue Hypoxia -The Concept of Supra-normal Values

  9. The first randomized controlled trialShoemaker et al. Chest 1988;94:1176 General surgery high risk patients. trauma, vascular, acute abdominal catastrophe, extensive ablative surgery Three groups 1. CVP control group 2. PAC control group 3. PAC protocol group. Goals of therapy C.I > 4,5 lit/min/m2, DO2>600ml/min/m2, Reduction in mechanical ventilation (9,4vs2.3) and ICU days (15,8vs10,2) 146 patients, 55 non randomized, 45 not ill enough, non consecutive enrolled, severity illness score not employed for baseline comparability, Co-interventions, hemodynamic and oxygen transport values for each group not reported.

  10. The beneficial effect of supranormalization of oxygen deliverywith dopexamine hydrochloride on perioperative mortality Boyd et al. JAMA 1993;270:2699-2707 • Dopexamine as the pharmacologic agent to increase DO2 • The intervention was initiated preoperative • Patients comparable at baseline • Pre and post op DO2 values were higher in the treatment group • 28 days mortality was lower in the treatment group • 6% vs 22% p< 0,015 • But • The median duration of ICU stay were 40 and 46 hours • In other studies ICU stay ranged from 5 to 24 days • The population in the study of Boyd at al was less critically ill.

  11. Elevation of systemic oxygen delivery in the treatment of critically ill patientsHayes et al. N Engl J Med 1994;330:1717-1722 • 100 patients • Dobutamine as the pharmacologic agent to increase DO2 • Randomization after standard fluid resuscitation • Mortality was higher in the treatment group 48% vs 30% • But • Delay to start the protocol • More seriously ill patients, higher APACHE score in the protocol group • Patients in the protocol group received more aggressive treatment • 50 mcg/kg/min Dobutamine and more than 68% Norepinephrine • 70% of the patients did not reach the supranormal value

  12. Large (762 patients) multi-center randomized trial Three groups Control group Supranormal C.I group Normal SvO2 group (>70%) Standard clinical care in all three groups MAP > 60 mmHg CVP=8-12 PAOP≤18mmHg Urine output≥0.5ml/kg pH ≥ 7,3-7,5 - 55% of the CI group failed to achieve a supranormal value

  13. The negative results of these study may be due to failure to achieve treatment goals rather than failure of treatment to influence outcome

  14. 7 randomized trials 1016 patients included Major problem: crossover of the patients Time of intervention Pre or postoperative in the ICU Timing of inotropic support Maximizing Oxygen delivery in critically ill patients: A methodologic appraisal of the evidence. Heyland et al. Crit Care Med 1996;24:517-24

  15. Treatment of Sepsis Hemodynamic Optimization Appropriate ATB treatment

  16. N Engl J Med 2001;345:1368-1377

  17. Chest 2006;

  18. Crit Care Med 2002;30:1686-92

  19. 21 randomized controlled trials Mortality reduction with hemodynamic optimization when treated early before MSOF when group mortality is >20% Crit. Care Med 2002;30:1686-92

  20. Conclusion • Sepsis related mortality and ICU-hospital LOS depends of: • Early detection or screening for high-risk patients • Early detection and treatment of tissue hypoxia • Early administration of appropriate antibiotic treatment • Providing education of all involved personnel

More Related